As of 2025-07-12, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 9.2x | 5.8x |
| Forward P/E multiples | 5.9x - 9.3x | 7.2x |
| Fair Price | (9.90) - (15.77) | (10.97) |
| Upside | -742.8% - -1124.2% | -812.5% |
| Date | EV/EBITDA |